In 1989, Karmanos Cancer Institute researcher Dr. Soule developed MCF-10, an immortal line of normal human breast cells. It was made to study the earliest changes a normal cell undergoes in becoming cancerous.

The cell line was the first of its kind to be cultured without the use of transforming agents, and is used to study the earliest changes a normal cell undergoes in becoming cancerous.